Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

Physicians Wait For Health IT Guidelines, Officials Want 'Every Doctor's Office' Online
Physicians are still waiting for clear cut rules for how they must use health information technology in order to be eligible for economic stimulus-funded incentives, American Medical News, a publication of the American Medical Association, reports. The publication notes that (the $2 billion) "incentive money will directly address the use of EMRs, not the purchase of the systems." The sole, ambiguous requirement - that doctors must make "meaningful use" of the technology - will be defined by year"s end. But, industry consultants say doctors can and should get a head start on the governments expectation that they"ll be able to adopt the technology by 2011. Practices can expect requirements to include e-prescribing, certification through a government-approved certifying body, quality reporting, and the ability of one system to exchange information with others (Dolan, 6/15).
generic viagra online
ChemGenex To Present Pivotal Data In T315I Positive CML Patients As Oral Presentation At ASCO
ChemGenex Pharmaceuticals Limited (ASX:CXS) (NASDAQ:CXSP) announced that updated clinical data from the registration-directed clinical trial of omacetaxine will be presented as an oral presentation at the forthcoming American Society of Clinical Oncology (ASCO) 45th Annual Meeting in Orlando, Florida.
plastic surgery before after
News of the day
Long-Suffering Rohingya In Bangladesh Face Unacceptable Abuse
Thousands of unregistered Rohingya refugees living in the Kutupalong makeshift camp, Bangladesh, are being forcibly displaced from their homes, in an act of intimidation and abuse by the local authorities. The international medical organization Doctors Without Border/Mç©decins Sans Frontiç¨res (MSF) has treated numerous people for injuries, of which the majority were women and children. Furthermore, MSF has witnessed countless destroyed homes and heard many reports of people being warned to remove their own shelters or face the consequences.
Public Health

Can Inflammatory Arthritis Be 'Worse Than Death'?

Patients with inflammatory arthritis completing a health-related quality of life questionnaire report levels of pain that result in their health being rated as "worse than death" by members of the general population. Researchers at the Arthritis Research Campaign Epidemiology Unit at the University of Manchester sought to identify why the health-related quality of life of a significant number of arthritis patients is rated so poorly, and to further investigate the health status of these patients. Arthritis patients report a range of limitations which impair their quality of life including very high levels of pain; this description of extreme pain was the consistent factor in explaining why certain patient"s quality of life was valued as "worse than death". Pain is the symptom of disease that people perceive to have the greatest detriment on quality of life and fear most as a consequence of disease. Rheumatoid arthritis is the most common form of inflammatory arthritis and affects half a million people in the UK. The disease is more common in women than in men. It is a potentially disabling disease with a considerable economic impact. Within ten years of onset of rheumatoid arthritis, at least 50% of patients are unable to hold down a full-time job. "Our findings highlight the burden of disease experienced by patients with arthritis. However quality of life valuations by the general population based on abstract health state descriptions, may not reflect the fact that treatments are available to relieve the pain of arthritis and alter the long-term outcome. We believe that further research is needed to see if the general public would rate this degree of pain differently if they had more information about the character of arthritis" says Dr Mark Harrison PhD of the University of Manchester. This will be discussed in Value in Health, the official journal of the International Society for Pharmacoeconomics and outcomes Research. Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research and help health care leaders to make decisions that are solidly evidence-based. The journal is published bi-monthly and has a regular readership of over 4,000 clinicians, decision-makers, and researchers worldwide. ISPOR is a nonprofit, international organization that strives to translate pharmacoeconomics and outcomes research into practice to ensure that society allocates scarce health care res wisely, fairly, and efficiently. ISPOR


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009